GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zevra Therapeutics Inc (FRA:1GDA) » Definitions » FCF Yield %

Zevra Therapeutics (FRA:1GDA) FCF Yield % : -23.72 (As of May. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Zevra Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Zevra Therapeutics's Trailing 12-Month Free Cash Flow is €-42.31 Mil, and Market Cap is €178.05 Mil. Therefore, Zevra Therapeutics's FCF Yield % for today is -23.72%.

The historical rank and industry rank for Zevra Therapeutics's FCF Yield % or its related term are showing as below:

FRA:1GDA' s FCF Yield % Range Over the Past 10 Years
Min: -351.74   Med: -9.87   Max: 6.68
Current: -23.72


During the past 11 years, the highest FCF Yield % of Zevra Therapeutics was 6.68%. The lowest was -351.74%. And the median was -9.87%.

FRA:1GDA's FCF Yield % is ranked worse than
62.21% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs FRA:1GDA: -23.72

Zevra Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was -471.98%.


Zevra Therapeutics FCF Yield % Historical Data

The historical data trend for Zevra Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zevra Therapeutics FCF Yield % Chart

Zevra Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,890.23 -47.95 3.33 -12.25 -13.96

Zevra Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.08 -21.01 -10.75 -26.79 -26.08

Competitive Comparison of Zevra Therapeutics's FCF Yield %

For the Biotechnology subindustry, Zevra Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zevra Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zevra Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Zevra Therapeutics's FCF Yield % falls into.



Zevra Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Zevra Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-31.023 / 222.210645
=-13.96%

Zevra Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.872 * 4 / 228.085225
=-26.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zevra Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Zevra Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Zevra Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zevra Therapeutics (FRA:1GDA) Business Description

Traded in Other Exchanges
Address
1180 Celebration Boulevard, Suite 103, Celebration, FL, USA, 34747
Zevra Therapeutics Inc is a rare disease company melding science, data and patient needs to create transformational therapies for diseases with limited or no treatment options. The firm's data-driven clinical, regulatory, and commercialization strategies overcome complex drug development challenges to bring much-needed therapies to patients. Its product candidate comprises Arimoclomol, orally delivered investigational product candidate for the treatment of Niemann-Pick type C (NPC). KP1077 is Zevra's lead clinical candidate being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy.

Zevra Therapeutics (FRA:1GDA) Headlines

No Headlines